Overview
Sehhoon Park practices in Seoul, Republic of Korea. Park is rated as an Advanced expert by MediFind in the treatment of Hepatic Venoocclusive Disease with Immunodeficiency. Their top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 108 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hepatic Venoocclusive Disease with Immunodeficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerPark isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung CancerPark isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)Park isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Hepatic Venoocclusive Disease with Immunodeficiency
- Experienced
- Acute Interstitial Pneumonia
- Adenoid Cystic CarcinomaPark isExperienced. Learn about Adenoid Cystic Carcinoma.
- Brain TumorPark isExperienced. Learn about Brain Tumor.
- CirrhosisPark isExperienced. Learn about Cirrhosis.
- Esophageal CancerPark isExperienced. Learn about Esophageal Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)